Other languages ClouDr Group Limited

Equities

9955

KYG2216H1011

Market Closed - Hong Kong S.E. Other stock markets 04:08:17 2024-05-17 EDT			5-day change	1st Jan Change
3.35 ^HKD	+1.21%		-2.33%	-51.09%

04-15	ClouDr Launches Digital Employee to Improve Online-to-Offline Operation Services	MT
03-22	ClouDr Group's Net Loss Shrinks 81% in 2023 as Revenue Rises 23.5%	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ClouDr Group's Net Loss Shrinks 81% in 2023 as Revenue Rises 23.5%	03-22
ClouDr Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-21
ClouDr Launches Diabetes Tablets; Shares Up 3%	03-11
ClouDr Group Limited Announces Launch of Proprietary Product, Hetangjin Dapagliflozin Tablets	03-10
ClouDr Group Limited Enters into A Non-Legally Binding Strategic Cooperation Agreement with China Resources Kunming Shenghuo Pharmaceutical Co., Ltd	03-05
ClouDr Buys Back Shares	01-25
ClouDr Group Limited Completes the Application for Registration as A Medical Device in the People's Republic of China in Respect of ClouDT-01	01-03
ClouDr Group Limited Enters into a Non-Legally Binding Strategic Cooperation Agreement with Shanxi Jinbo Bio-Pharmaceutical Co., Ltd	12-27
Cloudr Group Limited Announces Resignation of Liu Mengya as Joint Company Secretary	12-19
ClouDr Group Limited Announces New Efficacy of Ischelium on Brain Covidative Fund Approval	11-15
ClouDr Group Limited Enters into A Non-Legally Binding Strategic Cooperation Agreement with Hong Kong Magicure Medical Co., Ltd	23-09-07
ClouDr Group's H1 Loss Narrows	23-08-22
ClouDr Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18
ClouDr Group to Narrow H1 Loss	23-08-14
Cloudr Group Limited Launches Cloud GPT, ClouD DTx Platform and ClouDTx-CVD	23-05-11
ClouDr Group Limited Appoints Liu Xiaohua as the Chief Scientist	23-05-11
ClouDr Group's 2022 Attributable Loss Narrows	23-03-23
ClouDr Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22
ClouDr Group to Narrow FY22 Loss	22-12-05
ClouDr Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ending December 31, 2022	22-12-05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ClouDr Group Limited

Equities

9955

KYG2216H1011

Other languages

Filters